Jonathan Robson

ORCID: 0000-0003-1749-8450
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Head and Neck Cancer Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Global Cancer Incidence and Screening
  • Gastric Cancer Management and Outcomes
  • Cancer Diagnosis and Treatment
  • Cancer survivorship and care
  • Platelet Disorders and Treatments
  • Colorectal Cancer Screening and Detection
  • Cystic Fibrosis Research Advances
  • Systemic Sclerosis and Related Diseases
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Occupational and environmental lung diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Family Support in Illness
  • Tracheal and airway disorders
  • Dental Radiography and Imaging
  • Chronic Lymphocytic Leukemia Research
  • Biological Research and Disease Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Advanced Biosensing Techniques and Applications
  • Cancer-related molecular mechanisms research
  • Oral microbiology and periodontitis research

Leeds Teaching Hospitals NHS Trust
2014-2024

Griffith University
2021

St James's University Hospital
2013-2020

University College London
2020

Background Lung cancer outcomes in the UK are worse than many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage improve outcomes. Methods An early diagnosis campaign for lung commenced Leeds, 2011 comprising public and primary-care facing components. Rates of community referral chest X-ray (TNM seventh edition) presentation were collected from 2008 2015. Linear trends assessed by χ 2 test trend proportions. Headline figures presented 3 years...

10.1136/thoraxjnl-2018-211842 article EN Thorax 2018-06-27

To assess whether quality of life (QOL) was associated with cardiopulmonary complications following pulmonary lobectomy for lung cancer.Retrospective analysis 200 consecutive patients who had cancer (September 2014-October 2015). QOL assessed by the self-administration European Organisation Research and Treatment Cancer QLQ-C30 questionnaire within 2 weeks before operation. The individual scales were tested a possible association along other objective baseline surgical parameters univariable...

10.1093/ejcts/ezw363 article EN European Journal of Cardio-Thoracic Surgery 2016-11-29

Background: Lung cancer is increasingly a disease of the elderly and frail population with median age 70 years at diagnosis. Therefore, consideration impact interventions on health-related quality life (HRQOL) not only absolute survival especially important. For non-small cell lung (NSCLC), video-assisted thoracoscopic surgery (VATS) has been gaining popularity over last few decades, replacing traditional open lobectomies. high-risk patients who are deemed suitable for surgery, stereotactic...

10.21037/jtd.2017.07.35 article EN Journal of Thoracic Disease 2017-08-01

AURICULAR FIBRILLATION DRITJOS Factors which may precipitate auricular fibrillation include exercise, emotion, infection, and active carditis, but usually no cause is apparent.The onset of pass unnoticed or be responsible for dyspnoea, pulmonary oedema, infarction, systemic embolism, cardiac failure, loss consciousness, anxiety.Relative advantages established freedom from paroxysmal attacks, ease control heart rate with digitalis, comparative free- dom bacterial endocarditis.Persons tend to...

10.1136/bmj.2.4953.1418 article EN BMJ 1955-12-10

Introduction Optimal treatment for ‘potentially resectable’ stage III-N2 non-small cell lung cancer (NSCLC) requires multimodality treatment: local (surgery or radiotherapy) and systemic anticancer therapy. There is no clear evidence of superiority survival between the two approaches little research has explored quality life (QOL). This study will inform design a phase III randomised trial surgery versus as part NSCLC with QOL primary outcome. Methods analysis Patient participants be to...

10.1136/bmjresp-2020-000846 article EN cc-by-nc BMJ Open Respiratory Research 2021-07-01

<h3>Introduction</h3> Low dose CT screening reduced lung cancer mortality by 20% in the National Lung Screening Trial (NLST) using eligibility criteria of age 55–74 yrs, ≥30 pack year smoking history, and quit time &lt; 15 years. The US Preventative Services Task Force (USPSTF) has proposed NLST extending upper limit to 80 Alternative use thresholds from composite risk prediction scores such as a 1.51% over 6 years PLCO<sub>M2012</sub> model (derived Prostate Colorectal Ovarian Study) 5% 5...

10.1136/thoraxjnl-2016-209333.137 article EN Thorax 2016-11-15

The aim of this cross-sectional study was to understand patients' perceived importance clinic- and clinician-related factors contextual characteristics that shape the ratings for patients consider when accessing oral health care. This conducted at Griffith University Dental Clinic, Gold Coast, Australia. Patients answered a self-administered questionnaire on demographics need attendance, which constituted explanatory variables. In second part questionnaire, were asked rate 17 items related...

10.1071/py20205 article EN Australian Journal of Primary Health 2021-11-23

<h3>Abstract</h3> The US National Lung Screening Trial (NLST) identified persons for lung cancer screening by age (55–74 yrs) and smoking history, but a subsequent analysis of the SEER database showed that only 26.7% cases would have been eligible according to these criteria. Strategies increase proportion patients who might qualify include increasing upper limit 80 years (endorsed Preventative Services Task Force – USPSTF), using composite risk prediction tools. UK pilot (UKLS) used...

10.1136/thoraxjnl-2016-209333.135 article EN Thorax 2016-11-15
Coming Soon ...